| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association of KIR Genes Polymorphism and its HLA Ligands in Diffuse Large B-cell Lymphoma
|
Daniela Maira, Cardozo
|
|
|
23 |
6 |
p. 438-445
|
artikel
|
| 2 |
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study
|
Fu, Weijun
|
|
|
23 |
6 |
p. 446-455.e4
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
23 |
6 |
p. A1-A2
|
artikel
|
| 4 |
FDA Analysis of Ineligibility for Acute Myeloid Leukemia Clinical Trials by Race and Ethnicity
|
Pulte, Dianne
|
|
|
23 |
6 |
p. 463-470.e1
|
artikel
|
| 5 |
Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop
|
Terpos, Evangelos
|
|
|
23 |
6 |
p. 413-419
|
artikel
|
| 6 |
Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review
|
Fonseca, Rafael
|
|
|
23 |
6 |
p. 426-437.e11
|
artikel
|
| 7 |
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds
|
Scalzulli, Emilia
|
|
|
23 |
6 |
p. 420-425
|
artikel
|
| 8 |
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma
|
Wiedmeier-Nutor, Julia E.
|
|
|
23 |
6 |
p. 456-462
|
artikel
|
| 9 |
SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCL
|
Brazel, Danielle
|
|
|
23 |
6 |
p. 401-409
|
artikel
|
| 10 |
Table of Contents
|
|
|
|
23 |
6 |
p. A5-A6
|
artikel
|
| 11 |
The Goldilocks Dilemma in AML: Too Young and Fit, but Not Young and Fit Enough
|
St. Martin, Emma C.
|
|
|
23 |
6 |
p. 410-412
|
artikel
|
Tijdschrift beschrijving